Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study
about
Dyslipidaemia of diabetes and the intestineHighlights of the year in JACC 2012Mendelian randomization studies: a review of the approaches used and the quality of reportingEpidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.The influence of smoking and impaired glucose homoeostasis on the outcome in patients presenting with an acute coronary syndrome: a cross-sectional studyElevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective studyOxidative stress as a mechanism of added sugar-induced cardiovascular disease.A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Insulin resistance and hyperglycaemia in cardiovascular disease development.Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease.Mendelian randomization: where are we now and where are we going?Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease.Examining the causal association of fasting glucose with blood pressure in healthy children and adolescents: a Mendelian randomization study employing common genetic variants of fasting glucose.Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood sampling.
P2860
Q26799589-CE8A11FA-F008-42D6-BD69-DB804F4A300CQ26865608-D6609E5D-2C91-4A72-9632-51F893B5549AQ26999349-BB2C416B-88C4-483F-A403-EFD3F805E786Q30251632-0C076747-2400-4196-AD7A-88960AA9C09FQ30840447-72DBB964-EEE0-4565-B01D-CF7E152912BAQ33880043-5312FE0D-D46F-44AA-97AC-FD8E5E879D78Q34048554-3D3006CA-0D92-4ED8-916A-0511D143AB01Q34452521-D9517BC1-D0D8-44DB-A163-AF44FE86D37DQ35692664-FEF43130-605F-4D39-8CE4-F59E05F1F225Q37254899-D5B64264-45F4-4447-B567-C0A38395B063Q38198953-024A0632-15D5-475D-9662-A278C5FB3A0DQ38546242-E47A29F9-5A22-4E29-9092-725BE338D2CAQ38605091-9DA32EB6-615D-4A36-95DF-325D9F64190DQ38680846-83625191-7810-4CE7-BC84-3F41FE3C0176Q38704885-D5E3DF5B-F815-49BF-9B8C-4C5461E21A4AQ48456096-600191D1-2EC7-4E2B-A4BF-477D65CCD2C8Q51305542-BECD01AC-E7D5-462F-92D4-21407FAF4B22Q51318055-EF862C9B-8BFC-4BBE-A1B0-2FAEAF102122Q51326526-6505F500-A8CF-4594-B52C-286EAAEB16F8
P2860
Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@ast
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@en
type
label
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@ast
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@en
prefLabel
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@ast
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@en
P2860
P50
P1476
Nonfasting glucose, ischemic h ...... Mendelian randomization study
@en
P2093
Gorm B Jensen
Peer Grande
P2860
P304
P356
10.1016/J.JACC.2012.02.043
P407
P577
2012-06-01T00:00:00Z